Media Newsroom of

ARTIDIS AG

Follow on Social Network
Hochbergerstrasse 60C
4057 Basel
ARTIDIS AG

At ARTIDIS AG, we are committed to radically improving health outcomes by harnessing the power of nanotechnology and innovation. We enable rapid diagnosis and treatment optimization tailored to individual patient needs and desired outcomes.

ARTIDIS Gains Strong Momentum in 2019, Raising CHF 8.8 Million in Seed Financing

ARTIDIS Gains Strong Momentum in 2019, Raising CHF 8.8 Million in Seed Financing

The funding will be used to advance the company’s healthtech platform into a large multi-centre clinical study together with the University Hospital Tuebingen (Germany), University Hospital Barcelona (Spain), and Texas Medical Center (Houston, US). The study aims to further validate…

ARTIDIS Joins the TMC Accelerator Device Cohort to Ensure That Its Cancer Diagnostic and Therapeutic Optimization Innovation Gains Early Access to the US Market

ARTIDIS Joins the TMC Accelerator Device Cohort to Ensure That Its Cancer Diagnostic and Therapeutic Optimization Innovation Gains Early Access to the US Market

ARTIDIS is one of the 16 startups selected worldwide from more than 140 competing healthcare companies for the 9th TMC accelerator medical device cohort. After completing the TMC Accelerator Program that culminated with a Demo Day presentation on Nov. 7, 2019,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login